GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
ALLSCRIPTS HEALTHC (MDRX) [hlAlert]

Rating:
Buy MDRX
down 18.52 %

ALLSCRIPTS HEALTHC (MDRX) upgraded to Buy with price target $20 by Maxim Group

Posted on: Tuesday,  Feb 11, 2014  8:25 AM ET by Maxim Group

Maxim Group rated Buy ALLSCRIPTS HEALTHC (NASDAQ: MDRX) on 02/11/2014, when the stock price was $16.79. Since
then, ALLSCRIPTS HEALTHC has lost 18.52% as of 01/22/2016's recent price of $13.68.
If you would have followed this Maxim Group's recommendation on MDRX, you would have lost 18.52% of your investment in 710 days.

Allscripts-Misys Healthcare Solutions, Inc. (Allscripts), formerly Allscripts Healthcare Solutions, Inc., is a provider of clinical software, services, information and connectivity solutions used by the physicians and other health care providers. The Company?s businesses provide solutions that inform physicians with just right, just in time information, connect physicians to each other and to the entire community of care, and transforming healthcare. Allscripts provide various clinical software applications, including Electronic Health Records (EHR), practice management, revenue cycled management, clearinghouse services, electronic prescribing, Emergency Department Information System (EDIS), hospital care management and discharge management solutions, document imaging solutions, and a range of solutions for home care and other post-acute facilities. The Company operates in two business segments: clinical solutions and health solutions.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/11/2014 8:25 AM Buy
None
16.79 20.00
as of 10/17/2014
1 Week down  -2.87 %
1 Month down  -10.44 %
3 Months down  -22.34 %
1 YTD down  -23.40 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/18/2013 9:25 AM Hold
None
12.62
10/4/2012 8:25 AM Buy
None
12.81 15.00
12/18/2009 8:25 AM Buy
None
18.78 23.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy